2019
DOI: 10.2139/ssrn.3491115
|View full text |Cite
|
Sign up to set email alerts
|

Myopic Management Theory and R&D Investment Decisions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…The previous section has verified that managers would be more likely to practise myopic management on R&D investment decisions when listing. Theoretical models and studies show that managerial myopia can take many shapes and forms depending on the specific conditions the firm is operating in (Fedyk and Khimich, 2018; Oad Rajput et al ., 2019). Hence, this section separates the R&D myopic management into R&D over‐investment and under‐investment to fully examine hypothesis H3.…”
Section: Analysis and Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The previous section has verified that managers would be more likely to practise myopic management on R&D investment decisions when listing. Theoretical models and studies show that managerial myopia can take many shapes and forms depending on the specific conditions the firm is operating in (Fedyk and Khimich, 2018; Oad Rajput et al ., 2019). Hence, this section separates the R&D myopic management into R&D over‐investment and under‐investment to fully examine hypothesis H3.…”
Section: Analysis and Resultsmentioning
confidence: 99%
“…Given the high information asymmetry and the incentives to go public, managers would choose to make short‐term investment decisions in R&D to reach a favourable valuation, cater to investors' inclination and avoid long‐term costs (Xie et al ., 2020). Thus, considering the different specific conditions the IPO firm is operating in, managers could adopt many forms of myopic management in R&D, e.g., R&D over‐investment and under‐investment (Ahuja and Novelli, 2017; Fedyk and Khimich, 2018; Oad Rajput et al ., 2019; Dong et al ., 2020). However, investors who are not aware of these potential R&D management operations would be more likely to overvalue the security during IPOs.…”
Section: Related Literature and Hypotheses Developmentmentioning
confidence: 99%
“…Oad Rajput, Marwat, and Wongchoti (2019) compare the prevention of myopic and non-myopic companies in terms of financial strength. Myopic companies differ from nonmyopic companies in the level of leverage, cash ownership, sales growth, earned-to-capital ratio, dividend, age, and company size.…”
Section: Temporal Myopiamentioning
confidence: 99%
“…Furthermore, unexpected cuts in R&D and marketing may indicate a positive shift in financial flexibility. The positive change in financial flexibility attracts stock premiums and provides an incentive for overpricing, resulting in falling prices in the following years (Oad Rajput et al 2019). Conversely, the increase in the return on the stock of non-sighted companies is most likely due to higher financial flexibility, as nonsighted companies have low leverage and high cash holdings.…”
Section: Temporal Myopiamentioning
confidence: 99%